Cargando…

VENUSS rising for papillary renal cell carcinoma prognostication?

Detalles Bibliográficos
Autor principal:	Buchler, Tomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475457/ https://www.ncbi.nlm.nih.gov/pubmed/32953836 http://dx.doi.org/10.21037/atm.2020.03.216

Ejemplares similares

Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma
por: Piccinelli, Mattia L., et al.
Publicado: (2023)

Prognostic models in papillary renal cell carcinoma
por: Attalla, Kyrollis, et al.
Publicado: (2020)

The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort
por: Klatte, Tobias, et al.
Publicado: (2019)

Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing
por: Zhang, Zhen, et al.
Publicado: (2023)

Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture?
por: Daniels, Gilbert H.
Publicado: (2016)

Prognostic value of IKBIP in papillary renal cell carcinoma
por: Zhang, Huiling, et al.
Publicado: (2023)

Nonmelanoma Skin Cancer on the Rise
por: Wollina, Uwe
Publicado: (2012)

Clinicopathological Features and Prognostic Outcomes of Papillary Renal Cell Carcinoma
por: Qian, Xiaoyuan, et al.
Publicado: (2021)

The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
por: Rathi, Nityam, et al.
Publicado: (2019)

Rise and rise of anesthesiologists under the shadow of COVID-19
por: Gondode, Prakash Gyandev, et al.
Publicado: (2021)

The Role of Vitamin D as a Prognostic Marker in Papillary Thyroid Cancer
por: Bains, Ashank, et al.
Publicado: (2021)

Prognostic value of CDCA3 in kidney renal papillary cell carcinoma
por: Li, Hao, et al.
Publicado: (2021)

Retrospective comparison of the different immune combinations in metastatic renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2020)

Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma
por: Zhang, Yue, et al.
Publicado: (2019)

A short history of heme dioxygenases: rise, fall and rise again
por: Raven, Emma L.
Publicado: (2016)

Dermatophyte resistance – on the rise
por: Bristow, Ivan R., et al.
Publicado: (2023)

Identification of an independent autophagy-gene prognostic index for papillary renal cell carcinoma
por: Wei, Xiyi, et al.
Publicado: (2020)

Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma
por: Bellut, Julia, et al.
Publicado: (2017)

Long non-coding RNAs as prognostic biomarkers in papillary renal cell carcinoma
por: Yang, Feilong, et al.
Publicado: (2019)

Prognostic and Therapeutic Potential of the OIP5 Network in Papillary Renal Cell Carcinoma
por: Chow, Mathilda Jing, et al.
Publicado: (2021)

Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma
por: Wang, Yue, et al.
Publicado: (2023)

Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma
por: Mikuteit, Marie, et al.
Publicado: (2023)

Spatial proteomics enables identification of prognostic biomarkers in papillary renal cell carcinoma
por: Haake, Scott, et al.
Publicado: (2023)

Renal cell carcinoma with non-clear cell histology or sarcomatoid differentiation: recent insight in an unmet clinical need
por: Donskov, Frede
Publicado: (2021)

Implications of Rising Prediabetes Prevalence
por: Abraham, Tobin M., et al.
Publicado: (2013)

The rise of proteome‐wide biophysics
por: Mateus, Andre, et al.
Publicado: (2021)

Downregulation of PDZ Domain Containing 1 (PDZK1) is a Poor Prognostic Marker for Clear Cell Renal Cell Carcinoma
por: White-Al Habeeb, Nicole M.A.
Publicado: (2017)

The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017–2022
por: Hallinan, Christine Mary, et al.
Publicado: (2022)

The rising trend in papillary thyroid carcinoma: True increase or over diagnosis?
por: Hajeer, Manar H., et al.
Publicado: (2018)

The rising trend in papillary thyroid carcinoma: True increase or over diagnosis?
por: Shaukat, Arif A.
Publicado: (2018)

Papillary thyroid carcinoma variants with tall columnar cells
por: Jung, Chan Kwon
Publicado: (2020)

A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma
por: Wu, Zhipeng, et al.
Publicado: (2020)

Syntaxin 6: A novel predictive and prognostic biomarker in papillary renal cell carcinoma
por: Peak, Taylor C., et al.
Publicado: (2019)

Papillary Renal Cell Carcinomas Demonstrating Micropapillary Features: An Investigation Into the Diagnostic and Prognostic Implications
por: Caraballo, Beatriz, et al.
Publicado: (2022)

Rising inequality is not balanced by intergenerational mobility
por: Beckfield, Jason
Publicado: (2020)

The rise of a digital immune system
por: Schatz, Michael C, et al.
Publicado: (2012)

Commentary: The rise of minimalism in cardiac surgery
por: Di Tommaso, Ettorino, et al.
Publicado: (2021)

The rise and rise of Indian Journal of Ophthalmology
por: Honavar, Santosh G
Publicado: (2022)

Clear cell and papillary renal cell carcinomas in hereditary papillary renal cell carcinoma (HPRCC) syndrome: a case report
por: Ferlicot, Sophie, et al.
Publicado: (2021)

Incidence and therapeutic strategies for the management of pulmonary papillary cell carcinoma
por: Martin, Alvaro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g9c9n16rqtc63rrarv09g0cs47